Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiac Rhythmology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1650358

Phrenic nerve palsy during cryoballoon ablation of atrial fibrillation: a minor complication or a wolf in sheep's clothing? Insights on late arrhythmia recurrences from a propensity score-matched analysis

Provisionally accepted
  • 1Santa Maria delle Croci Hospital, Ravenna, Italy
  • 2Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
  • 3Universitair Ziekenhuis Brussel, Brussels, Belgium
  • 4Ospedale Santa Maria delle Croci, Ravenna, Italy
  • 5IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy

The final, formatted version of the article will be published soon.

Background: Pulmonary vein isolation (PVI) has become the cornerstone of percutaneous atrial fibrillation (AF) treatment, and cryoballoon ablation (CB-A) has been shown to be non-inferior to radiofrequency (RF) ablation in terms of safety and efficacy. Hemi diaphragmatic paralysis, secondary to right phrenic nerve palsy (PNP), is the most common complication associated with cryoballoon ablation, occurring in 1.1%–6.2% of procedures. Although, in the literature, PNP appears to not jeopardize the acute electrical isolation of the right-sided pulmonary veins, its occurrence forces the electrophysiologist to immediately stop cryoenergy delivery, thus resulting in a shorter cryo-application time. Aims: The purpose of the analysis is to understand whether the occurrence of intraprocedural PNP can be related to an increased risk of developing atrial fibrillation/atrial flutter (AT/AF) recurrences during the follow-up. Methods and results: We retrospectively enrolled 116 consecutive patients who experienced PNP during PVI using the second-generation cryoballoon. This group was compared using 1:1 propensity score (PS) and caliper matching with a cohort of patients who did not present PNP. After the matching, 108 patients with CB-A related phrenic nerve palsy (PNP+ group) were analyzed and compared with 108 patients who did not experienced PNP (PNP-group). After a median follow-up of 19 [12.0, 31.0] months, the success rate was significantly lower in the PNP+ group compared to the control group (57.4% vs. 78.7%, Log-Rank p = 0.001). Patients with a history of PNP had an almost threefold higher risk of developing arrhythmia recurrences during follow-up compared to their counterparts (HR: 2.813, 95% CI: 1.470 – 5.385, p = 0.002). Patients who experienced PNP showed a trend toward a higher need for RF touch-up compared to the counterpart (p = 0.06). Left atrial diameter (Lad), need of cardioversion to restore sinus rhythm after PVI, together with PNP were found to be independent predictors of late arrhythmia relapses. No major complications occurred in the entire population. Conclusions: The present study showed that PNP, although typically reversible and without long-term sequelae, is associated with a significantly lower success rate of CB-A PVI and a higher risk of arrhythmia recurrences.

Keywords: Phrenic nerve palsy, Atrial Fibrillation, Cryoballoon ablation, Pulmonary vein isolation, Propensity Score

Received: 19 Jun 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 CECCHINI, Mugnai, Maj, Rubboli, Del Monte, Della Rocca, Almorad, Sieira, Marinelli, Costa, Bonapace, Molon, Sarkozy, Chierchia and de Asmundis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: FEDERICO CECCHINI, Santa Maria delle Croci Hospital, Ravenna, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.